Ruiz-Falcó Rojas, M. L., Feucht, M., Wilken, B., Hahn, A., Maamari, R., & Macaya Ruíz, A. (2022). Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results.
Citação norma ChicagoRuiz-Falcó Rojas, María Luz, Martha Feucht, Bernd Wilken, Andreas Hahn, Ricardo Maamari, y Alfons Macaya Ruíz. Real-World Evidence Study On the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results. 2022.
Citação norma MLARuiz-Falcó Rojas, María Luz, et al. Real-World Evidence Study On the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results. 2022.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.